We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.
RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
Effect of carotid chemoreceptor denervation on breathing during ventrolateral medullary cooling in goats.
Journal of Applied Physiology 1995 October
It has been postulated that the so-called area S of the ventrolateral medulla (VLM) integrates peripheral chemoreceptor activity; thus cooling-induced dysfunction of neurons in this VLM area should functionally eliminate carotid chemoreceptor stimulation of breathing. Accordingly, carotid chemoreceptor denervation (CBD) should not alter the breathing effects of VLM neuronal dysfunction. To test this hypothesis in awake goats, chronically implanted thermodes were used to cool the VLM and thereby cause reversible neuronal dysfunction in all or portions of VLM areas M and S. Within 5 s after initiation of cooling approximately 60-100% of areas M and S in (P < 0.05) uniformly over conditions of eupnea, hypercapnia, and hypoxia. Between 10 and 20 s of cooling, the reduction in VI was approximately 10% greater (P < 0.05) during hypercapnia than during eupnea and hypoxia. For the remaining 10 s of cooling and for approximately 1 min after cooling, VI increased to and above control for all conditions. For all conditions, CBD accentuated the depression of VI during cooling, causing VI to decrease (P < 0.05) 10-40% more than before CBD. After CBD, the greatest effect on VI of cooling was again during hypercapnia. Thus the carotid bodies in intact goats appear to sense blood gas errors caused during VLM cooling to minimize the decreases in VI. We conclude that the data from this study do not support the concept that the VLM integrates carotid chemoreceptor activity.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app